Fosun Pharma says will buy Israel's Alma Lasers Ltd for $240 million
HONG KONG (Reuters) - Shanghai Fosun Pharma (Group) Ltd (600196.SS) said on Sunday it would spend up to $240 million to acquire up to 96.6 percent of Israel-based Alma Lasers Ltd (ALMA.O), a manufacturer of lasers used in cosmetic surgery.
It is the first major buyout deal by Fosun Pharma since it listed on the Hong Kong Stock Exchange last October.
Fosun Pharma, a subsidiary of China's Fosun International Limited (0656.HK), said it would make the investment together with Pramerica-Fosun China Opportunity Fund, a US-dollar denominated investment fund owned by Fosun Group.
(Reporting by Lawrence White)